Lisl Dunlop has 30 years of experience in antitrust and competition issues, including counseling, litigation, and transactions. Lisl guides clients through the antitrust-related aspects of mergers and acquisitions, joint ventures and other combinations, and sales and distribution matters. She also represents clients in antitrust agency investigations, and has represented major corporations in complex antitrust litigations.
Lisl has significant experience advising leading U.S. and multinational companies in a broad range of industries, including the media, technology, cannabis, and health care sectors. For her health care clients, Lisl provides antitrust and strategic advice in evaluating value-based payment initiatives, the establishment and operation of ACOs and independent physician networks, financial and clinical integration issues, and other transactions and collaborations.
Lisl began her career in Australia, and in addition to the U.S. has also practiced in the UK. Her wide-ranging international experience includes appearing before U.S. federal and state antitrust enforcement agencies, the European Commission, and UK and Australian antitrust authorities. Additionally, she has coordinated the multijurisdictional defense of transactions throughout the world. Lisl’s experience in competition matters in a broad range of jurisdictions brings added value to clients that conduct business internationally and interact with different legal systems and regulators.
Regularly recognized as an antitrust leader, Lisl has been ranked in Chambers USA, Legal 500, Who’s Who Legal, and Global Competition Review and is a frequent author and speaker on issues involving antitrust and competition law.
More »
Professional Activities
- New York State Bar Association Antitrust Section – Chair (2016); Executive Committee member
- American Bar Association, Editorial Board for the 9th Edition of Antitrust Law Developments (2020-22)
- American Bar Association Section of Antitrust Law – Competition Standards Task Force (2019-21)
- American Bar Association, Health Law Section
- American Health Lawyers Association, Antitrust Practice Group—Member
- Law360 Competition Editorial Advisory Board (2019)
Experience
- Represented Heart of Hospice in its acquisition by LHC Group
- Represented Tyson Foods in its sale of pet treats business to General Mills
- Represented Columbia Care in its acquisitions of The Green Solution and Green Leaf Medical
- Represented Tufts Health Plan in its merger with Harvard Pilgrim Health Care.
- Represented Textron Inc. in pilot training joint venture with FlightSafety Inc.
- Represented Peter Adderton and Boost International in opposing the Sprint/T-Mobile merger
- Authored amicus brief for Nashville Songwriters’ Association International in United States v. Broadcast Music, Inc., Second Circuit, 2017
- Defended Kaiser Foundation Health Plan and Kaiser Foundation Hospitals in NorthBay Healthcare Group, Inc. v. Kaiser Foundation Health Plan, Inc. in the Northern District of California
- Represented Mount Sinai in its acquisition of South Nassau Community Hospital
- Represented Stamps.com in its acquisitions of Endicia and MetaPack
- Represented Mann+Hummel in its acquisitions of Affinia and Tri-Dim
- Represented Hetero in the sale of Invagen to Cipla
- Represented Lutheran Medical Center in its acquisition by NYU/Langone
- Represented Textron/Cessna in its acquisition of Beechcraft
- Represented Ardagh Group in its acquisition of Saint Gobain Containers
* Includes matters handled prior to joining Axinn
Honors
- Chambers USA – New York: Antitrust (2010 – 2022)
- Crain's New York Business – Notable Women in Law (2020)
- Best Lawyers in America (2020 – 2023)
- The Legal 500 United States (2012 – 2014; 2022)
- Named a top author in JD Supra's Readers' Choice Awards (2017 – 2018)
- Who's Who Legal: Competition (2020 – 2022)
- Named to "Women Worth Watching 2022" by Profiles in Diversity Journal
- Super Lawyers, Top Women Attorneys – New York Metro (2011 – 2022)
Thought Leadership
- USA: Law and Practice, Chambers Global Practice Guides – Merger Control 2022, August 8, 2022
- Amazon-One Medical Deal: Scrutiny Likely, Lawsuit Not, Law360, July 22, 2022
- Second Circuit: Southern District of New York - Edition 3, Global Competition Review, June 24, 2022
- Labor Markets in Healthcare Transactions: A Work in Progress, CPI Antitrust Chronicle, June 1, 2022
- FTC’s Baby Formula Inquiry Tees up a Look at Tariffs, Subsidies, Bloomberg Law, May 27, 2022
- Antitrust Litigation is Coming to Cannabis, Cannabis Business Executive, May 25, 2022
- Advocate Aurora-Atrium’s Mammoth Merger: Experts Split On Whether Federal Regulators Will Challenge the Deal, STAT, May 11, 2022
- Big Trouble for Biglari Under the HSR Act – and Why Cannabis Operators Should Take Note, Cannabis Business Executive, March 2, 2022
- Lina Khan is Rewriting the FTC's Rulebook, Law360, February 9, 2022
- Who’s Who Legal – Thought Leaders Competition 2022, January 18, 2022
- Top Ten 2022: Provider M&A Faces New Antitrust Headwinds, AHLA Speaking of Health Law, January 14, 2022
- Merger Cases, Issues to Watch in 2022, Law360, January 3, 2022
- Top Ten Issues in Health Law 2022, AHLA Health Law Connections, January 1, 2022
- The Major Antitrust Conduct Cases of 2021, Law360, December 20, 2021
- Antitrust and Healthcare Inequity, Eleanor M. Fox Liber Amicorum - Antitrust Ambassador to the World, October 27, 2021
- FTC Withdraws Approval of 2020 Vertical Merger Guidelines, GCR, September 16, 2021
- Dealmakers Face Uncertainty Following Merger Guidelines Repeal, The Deal, September 15, 2021
- FTC to Take on Trump’s Vertical Merger Guidelines, Politico, September 15, 2021
- Bills to Speed Generic Entry Once Again Clear Senate Judiciary Committee, The Pink Sheet, July 29, 2021
- Senate Panel OKs Antitrust Package Aimed at Drug Pricing, Law360, July 29, 2021
- Second Circuit: Southern District of New York – Edition 2, Global Competition Review, July 2021
- A Tougher M&A Regulatory Environment, Pharma Manufacturing, June 25, 2021
- Health Care Antitrust Enforcement Homes in on Non-Hospital Transactions, AHLA PG Briefing, June 25, 2021
- Health Insurance Compliance Steps After Antitrust Reform, Law360, April 7, 2021
- DOJ Resolves Case Against Pennsylvania Healthcare Providers, GCR USA, March 4, 2021
- The Next Four Years: Antitrust Enforcement on an Upward Trajectory, Concurrences Competition Law Review, January 19, 2021
- A Look at the Recent DOJ Complaint in U.S. v. Geisinger, AHLA Speaking of Health Law, October 12, 2020
- Second Circuit: Southern District of New York, GCR Insight: U.S. Courts Annual Review, July 24, 2020
- Who’s Who Legal – Thought Leaders Competition, Who’s Who Legal, December 2019
- Judge Moves Aetna / CVS Deal Into Unchartered Tunney Act Waters, Bloomberg Law, June 4, 2019
- Navigating Vertical Mergers in Healthcare Through a Shifting Enforcement Landscape, Competition Policy International, May 7, 2019
- The Capitol Forum Thought Leaders Series, April 25, 2019
- New York Attorney General's Cartel Bust Is Just the Beginning, Crain's New York Business, June 18, 2018
- Net Neutrality: From Rules to Enforcement, Electronic Retailing Association, December 20, 2017
- Certificates of Public Advantage: Bypassing the FTC in Healthcare Mergers?, Competition, Vol 27, No. 1, Fall 2017
- When a Firm is "Failing": CentraCare vs. Energy Solutions, Law360, August 25, 2017
- Why Amazon's Whole Foods Buy is Likely to be Cleared, Law360, June 27, 2017
- Merger Control in the United States: Overview, Practical Law: Thomson Reuters, June 1, 2017
- Geographic Market Definition in Hospital Merger Antitrust Enforcement, New York Law Journal, January 23, 2017
- Merger Control in the United States: Overview, Practical Law: Thomson Reuters, June 1, 2016
- Restraints of Trade and Dominance in the United States: Overview, Practical Law: Thomson Reuters, June 1, 2016
- Merger Control in the United States: Overview, Practical Law, Thomson Reuters, September 1, 2015
- Restraints of Trade and Dominance in the United States: Overview, Practical Law: Thomson Reuters, September 1, 2015
- FTC's Use of "Disgorgement" Poses New Risks for Healthcare Industry, Modern Healthcare, August 24, 2015
- Messages in a Bottle: Defense Perspectives from the Ardagh/Saint Gobain Case, The Threshold, Summer 2014
- Allocating Antitrust Risk in M&A Agreements, CPI Antitrust Chronicle, April 2013
- The FTC is Shifting Gears on Monetary Remedies: Should You Be Worried?, The Antitrust Counselor, October 2012
- Mergers and Acquisitions, American Bar Association, 2009
- The Many Faces of Administrative Adjudication in the European Union, 61 Admin. L. Rev. 131 (2009), 2009
- Administrative Law of the European Union: Adjudication, American Bar Association, 2008
- Mergers and Acquisitions, American Bar Association, 2008
Events
- "Reflections on Women in Law" Panel and Diversity Networking Event
- AHLA Health Care Antitrust Hot Topics Webinar
- PLI Antitrust Counseling and Compliance 2022
- CompLaw EU Merger Control Conference
- CompLaw Antitrust Midwest Conference 2022
- ABA Antitrust in Healthcare Conference 2022
- Health Plan Law and Compliance Institute 2022
- AHLA Health Care Transactions Program 2022
- AHLA Women's Forum 2022
- Antitrust Enforcement Trends in Digital Markets in the U.S. and U.K.
- PLI Antitrust Counseling and Compliance 2021
- ACI Life Sciences Antitrust 2021
- Axinn Webinar: Hot Topics in Health Care Deals – Key Takeaways from the AHLA Health Care Transactions and Antitrust Conferences
- AHLA Health Care Antitrust: Meeting the Challenge Program
- Concurrences Antitrust Compliance Awards
- Healthcare Merger Recap: Managing Multiple Regulatory Reviews
- PLI’s 2020 Antitrust Counseling & Compliance Program
- ABA Monthly Update for Corporate Counsel September 2020
- ABA 2020 ILS Virtual Annual Meeting
- Key Antitrust Issues in the Healthcare Industry
- PLI's 2019 Antitrust Counseling & Compliance Program
- Practical Antitrust Perspectives From Government Enforcers
- 2019 Centerforce Women, Diversity & Change Summit - San Francisco
- Global Antitrust Practice in the 2020s: Lessons From Europe and the United States, Including Cartel Defense Strategy, Platform Markets, and More
- PLI's 2019 Developments in Antitrust Law & Regulation Program
- ABA 67th Annual Section of Antitrust Law Spring Meeting
- NYSBA Antitrust Expert Training Academy
- ABA 4th Annual Antitrust Merger Practice Workshop
- 2018 Retail Law Conference
- 2018 Credit Suisse Health Insurance Symposium
- ABA and AHLA Antitrust in Healthcare Conference
- DSRIP Antitrust Considerations: The Case for a COPA
- 2017 PLI Antitrust Counseling & Compliance Conference
- Mapping the Healthcare M&A Landscape Under the New Administration
- Recent Developments in Health Care and Pharmaceuticals
- 2017 National Association of Women Lawyers' Mid-Year Meeting
- When Competition Concerns Arise in Health Systems Combinations: Litigation Versus Regulation
- Introduction to Antitrust Basics
- 2016 PLI Antitrust Counseling & Compliance Conference
- Antitrust Cases Involving Financial Benchmarks: Issues of Conspiracy and Standing
- Key Legal Issues in U.S. Mergers and Acquisitions for European Lawyers
- Electrical Products Group Conference
- State Action Issues in the Wake of the North Carolina Dental Board Decision
- 2016 PLI Antitrust Institute Developments & Hot Topics Conference
- 2015 PLI Antitrust Counseling & Compliance Conference
- 2015 ABA Section of International Law Asia Forum
- Successful Transactions – What In-House Counsel Expect from Their M&A and Antitrust Attorneys
- 2013 NYSBA Antitrust Section Annual Meeting
- 2013 PLI Antitrust Counseling & Compliance Conference
- GCR Live 2nd Annual Antitrust Law Leaders Forum
- 2012 ABA Section of Antitrust Law Spring Meeting
- Women in Financial Services
- 2012 NYSBA Antitrust Section Annual Meeting
- Antitrust in Latin America – What’s Going On?
- Premerger Information Exchange
- 2011 ABA Section of Antitrust Law Spring Meeting
- Antitrust Litigation Forum
- 2010 ABA Section of Antitrust Law Spring Meeting
- Mergers from Strategy to Hearing: Part 2 – Pre-Merger Filings
- Meet the Economist Enforcers II: A Dialogue with Christian Ewald of the Bundeskartellamt and Amelia Fletcher of the UK OFT
- 2007 ABA Section of Antitrust Law Spring Meeting
- 2006 ABA Section of Antitrust Law and New York City Bar Conference
- 2005 ABA Section of Administrative Law Midyear Meeting
Education
- LLM – Cornell University Law School (1997)
- LLB – University of Sydney (1991)
- BSc – University of Sydney (1991)
Admissions
- New York
- District of Columbia
- Australia
- England and Wales
- US Supreme Court
- US Court of Appeals for the Second Circuit
- US District Court Eastern District of New York
- US District Court Southern District of New York
- US District Court District of Columbia
Spotlight
"Lisl is highly responsive and she can handle any antitrust question that arises."
– Chambers USA 2022
"Lisl Dunlop wins commendations from peers across North America who consider her a go-to figure in the market for antitrust-related litigation and transactional matters."
– Who's Who Legal 2019